Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
The Technology Select Sector SPDR® Fund
XLK
4
Invesco Solar ETF
TAN
5
Invesco DB Commodity Index Tracking Fund
DBC
US Stock MarketDetailed Quotes
Myriad Genetics (MYGN)
- 4.070
- -0.140-3.33%
Close May 12 16:00 ET
- 4.070
- 0.0000.00%
Post 20:01 ET
384.40MMarket Cap-0.94P/E (TTM)
4.240High4.070Low1.18MVolume4.200Open4.210Prev Close4.85MTurnover1.49%Turnover RatioLossP/E (Static)94.45MShares8.59052wk High1.14P/B321.87MFloat Cap3.75052wk Low--Dividend TTM79.08MShs Float69.000Historical High--Div Yield TTM4.04%Range %1.438Historical Low4.125Avg Price1Lot Size
MYGN Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
MYGN Orderflow
Unit: --
MYGN Orderflow Trend
IntradayDayWeekMonth
No Data
Myriad Genetics (MYGN) News
Global Liquid Biopsy Market Projected to Hit USD 7.05 Billion by 2030 | MarketsandMarkets
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
BofA Securities Maintains Myriad Genetics(MYGN.US) With Sell Rating
Myriad Genetics Price Target Lowered to $6 From $7 at TD Cowen
Myriad Genetics Bets on Growth Amid Profit Squeeze
Myriad Genetics Price Target Cut to $6.00/Share From $7.00 by TD Cowen
Myriad Genetics (MYGN) Stock Forum
$Myriad Genetics (MYGN.US)$ Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
3 MINUTES AGO, 9:05 AM EDT
VIA GLOBENEWSWIRE
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, reveals that Americans feel mental health treatmen...
3 MINUTES AGO, 9:05 AM EDT
VIA GLOBENEWSWIRE
SALT LAKE CITY, April 30, 2026 (GLOBE NEWSWIRE) -- The latest GeneSight® Mental Health Monitor, a nationwide survey from Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, reveals that Americans feel mental health treatmen...
$Myriad Genetics (MYGN.US)$ Will share six abstracts, including two podium presentations, at the American Association for Cancer Research (AACR) Annual Meeting 2026.
The company will share new results from the MONITOR-Breast study, a prospective, multi-center clinical trial evaluating the performance of Precise MRDTM in breast cancer across all phases of the treatment journey. The data will be shared in a podi...
The company will share new results from the MONITOR-Breast study, a prospective, multi-center clinical trial evaluating the performance of Precise MRDTM in breast cancer across all phases of the treatment journey. The data will be shared in a podi...
8
1
$Myriad Genetics (MYGN.US)$ Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (Niraparib) for Patients With Ovarian Cancer
GlobeNewswire
53m
Approval reinforces Myriad's leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the United States
SALT LAKE CITY, March 17, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecul...
GlobeNewswire
53m
Approval reinforces Myriad's leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the United States
SALT LAKE CITY, March 17, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecul...
1
⚠️ READ THIS BEFORE YOU TRADE ⚠️
1. NFA — Nothing here is financial advice. I am not your financial advisor, and this is NOT a buy/sell alert.
2. Trade with confirmation. Always check the chart, volume, momentum, order book, and short availability before touching a position.
3. Manage risk like a pro. Scale out, take profits, use stops. If you’re guessing instead of planning, you’re gambling.
4. Your P&L is yours. Wins are yours to celebrate, ...
1. NFA — Nothing here is financial advice. I am not your financial advisor, and this is NOT a buy/sell alert.
2. Trade with confirmation. Always check the chart, volume, momentum, order book, and short availability before touching a position.
3. Manage risk like a pro. Scale out, take profits, use stops. If you’re guessing instead of planning, you’re gambling.
4. Your P&L is yours. Wins are yours to celebrate, ...
+12
28
3
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)